Progress on radionuclide-labeled small peptides in targeting tumor angiogenesis / 中国肿瘤临床
Chinese Journal of Clinical Oncology
;
(24): 68-72, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-507313
ABSTRACT
Early diagnosis and precision medicine generally show significant differences in the prognosis of patients with carcinoma. Angiogenesis not only plays a key role in tumor pathophysiology but also acts as an important drug target. Peptides with specific se-quences can target specific molecules on the endothelial cellular membrane during tumor angiogenesis. Radionuclide-labeled molecu-lar probes exhibit many advantages in oncotherapy. This article focuses on the progress of radionuclide-labeled RGD and RRL in radio-immunoimaging and radioimmunotherapy targeting tumor angiogenesis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio de tamizaje
Idioma:
Chino
Revista:
Chinese Journal of Clinical Oncology
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS